| Overview |
| bs-8035R-Cy3 |
| GABARAPL1 Polyclonal Antibody, Cy3 Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Rat |
| Human, Mouse, Dog, Cow, Pig, Rabbit |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human GABARAPL1 |
| 41-117/117 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 23710 |
| Cytoplasm, Cell membrane |
| APG8 like; APG8L; ATG8; ATG8L; Early estrogen regulated protein; GABA; GABAA receptor associated protein like 1; GABARAPL1; Gamma aminobutyric acid receptor associated protein like 1; GEC 1; GEC1; Glandular epithelial cell protein 1; GBRL1_HUMAN. |
| GABARAPL1 belongs to the MAP1 LC3 family. It increases cell surface expression of kappa type opioid receptor through facilitating anterograde intracellular trafficking of the receptor. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz